SPRB SCHEDULE 13G/A: SEC filing

OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC

Filed with the SEC on · accession 0000947871-26-001033

SPRB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC filed an amended Schedule 13G reporting beneficial ownership of Spruce Biosciences common stock, with OrbiMed Advisors and Genesis each holding 162,000 shares (5.6%) and OrbiMed Capital holding 80,800 shares (2.8%), for an… The stock moved -2.4% by the first close after the filing.

Summary of the filing

OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC filed an amended Schedule 13G reporting beneficial ownership of Spruce Biosciences common stock, with OrbiMed Advisors and Genesis each holding 162,000 shares (5.6%) and OrbiMed Capital holding 80,800 shares (2.8%), for an aggregate of 8.5%.

Key details

Shares beneficially owned by OrbiMed Advisors LLC$162K
Shares beneficially owned by OrbiMed Genesis GP LLC$162K
Shares beneficially owned by OrbiMed Capital LLC$81K
Reporting person / beneficial ownerOrbiMed Advisors LLC
Reporting person / beneficial ownerOrbiMed Genesis GP LLC
Reporting person / beneficial ownerOrbiMed Capital LLC
IssuerSpruce Biosciences, Inc.
Member, orbimed advisors llc / orbimed genesis gp llc / orbimed capital llcCarl L. Gordon

How SPRB stock reacted

Close before

$43.31

Nov 13, 2026

First close after

-2.45%

$42.25

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for SPRB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SPRB?

Click here

Frequently asked questions

What did SPRB file with the SEC on Nov 16, 2026?

SPRB filed a SCHEDULE 13G/A (SEC filing). OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC filed an amended Schedule 13G reporting beneficial ownership of Spruce Biosciences common stock, with OrbiMed Advisors and Genesis each holding 162,000 shares (5.6%) and OrbiMed Capital holding 80,800 shares (2.8%), for an aggregate of 8.5%.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did SPRB stock react to this filing?

SPRB closed at $43.31 before the filing and $42.25 on Nov 16, 2026 (-2.45%).

Other SPRB SEC filings

Get alerts when SPRB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days